Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis

Molecular Microbiology

Volumn 86, Issue 2, 2012, Pages 367-381

  Kumar, Pradeep ^a   Arora, Kriti ^a   Lloyd, John R ^b   Lee, Ill Y ^a,c   Nair, Vinod ^d   Fischer, Elizabeth ^d   Boshoff, Helena I M ^a   Barry, Clifton E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE TRANSPEPTIDASE; CLAVULANIC ACID; DACB2 PROTEIN; MEROPENEM; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DOWN-REGULATION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SERINE-TYPE D-ALA-D-ALA CARBOXYPEPTIDASE; THIENAMYCINS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 84867471468     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2012.08199.x     Document Type: Article

References (49)

1. Arbeloa, A., Hugonnet, J.E., Sentilhes, A.C., Josseaume, N., Dubost, L., Monsempes, C., etal. (2004) Synthesis of mosaic peptidoglycan cross-bridges by hybrid peptidoglycan assembly pathways in gram-positive bacteria. J Biol Chem 279: 41546-41556.
2. Atrih, A., and Foster, S.J. (1999) The role of peptidoglycan structure and structural dynamics during endospore dormancy and germination. Antonie Van Leeuwenhoek 75: 299-307.
3. Barry, C.E., 3rd, Lee, R.E., Mdluli, K., Sampson, A.E., Schroeder, B.G., Slayden, R.A., and Yuan, Y. (1998) Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res 37: 143-179.
4. Barry, C.E., Crick, D.C., and McNeil, M.R. (2007) Targeting the formation of the cell wall core of M. tuberculosis Infect Disord Drug Targets 7: 182-202.
5. Baum, E.Z., Crespo-Carbone, S.M., Foleno, B., Peng, S., Hilliard, J.J., Abbanat, D., etal. (2005) Identification of a dithiazoline inhibitor of Escherichia coli L, D-carboxypeptidase A. Antimicrob Agents Chemother 49: 4500-4507.
6. Bergval, I.L., Schuitema, A.R., Klatser, P.R., and Anthony, R.M. (2009) Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. J Antimicrob Chemother 64: 515-523.
7. Bourai, N., Jacobs, W.R., and Narayanan, S. (2012) Deletion and overexpression studies on DacB2, a putative low molecular mass penicillin binding protein from Mycobacterium tuberculosis H(37)Rv. Microb Pathog 52: 109-116.
8. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., etal. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4: 702-707.
9. Cohen, T., Colijn, C., Wright, A., Zignol, M., Pym, A., and Murray, M. (2008) Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med 177: 1302-1306.
10. Driehuis, F., and Wouters, J.T. (1987) Effect of growth rate and cell shape on the peptidoglycan composition in Escherichia coli J Bacteriol 169: 97-101.
11. England, K., Boshoff, H.I., Arora, K., Weiner, D., Dayao, E., Schimel, D., etal. (2012) Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo. Antimicrob Agents Chemother 56: 3384-3387.
12. Flores-Valdez, M.A., Morris, R., Laval, F., Daffe, M., and Schoolnik, G.K. (2009) Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system. FASEB J 23: 4091-4104.
13. Ghuysen, J.M. (1977) The concept of the penicillin target from 1965 until today. The thirteenth Marjory Stephenson memorial lecture. J Gen Microbiol 101: 13-33.
14. Glauner, B. (1988) Separation and quantification of muropeptides with high-performance liquid chromatography. Anal Biochem 172: 451-464.
15. Glauner, B., Holtje, J.V., and Schwarz, U. (1988) The composition of the murein of Escherichia coli J Biol Chem 263: 10088-10095.
16. Goffin, C., and Ghuysen, J.M. (2002) Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol Mol Biol Rev 66: 702-738.
17. Gupta, R., Lavollay, M., Mainardi, J.L., Arthur, M., Bishai, W.R., and Lamichhane, G. (2010) The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin. Nat Med 16: 466-469.
18. Hash, J.H. (1963) Purification and properties of staphylolytic enzymes from Chalaropsis sp. Arch Biochem Biophys 102: 379-388.
19. Hash, J.H., and Rothlauf, M.V. (1967) The N, O-diacetylmuramidase of Chalaropsis species. I. Purification and crystallization. J Biol Chem 242: 5586-5590.
20. Hugonnet, J.E., Tremblay, L.W., Boshoff, H.I., Barry, C.E., 3rd, and Blanchard, J.S. (2009) Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis Science 323: 1215-1218.
21. Inohara, C., McDonald, C., and Nunez, G. (2005) NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 74: 355-383.
22. Johnston, J.C., Shahidi, N.C., Sadatsafavi, M., and Fitzgerald, J.M. (2009) Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE 4: e6914.
23. Kato, K., Strominger, J.L., and Kotani, S. (1968) Structure of the cell wall of Corynebacterium diphtheriae. I. Mechanism of hydrolysis by the L-3 enzyme and the structure of the peptide. Biochemistry 7: 2762-2773.
24. Kotani, S., Yanagida, I., Kato, K., and Matsuda, T. (1970) Studies on peptides, glycopeptides and antigenic polysaccharide-glycopeptide complexes isolated from an L-11 enzyme lysate of the cell walls of Mycobacterium tuberculosis strain H37Rv. Biken J 13: 249-275.
25. Lavollay, M., Arthur, M., Fourgeaud, M., Dubost, L., Marie, A., Veziris, N., etal. (2008) The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L, D-transpeptidation. J Bacteriol 190: 4360-4366.
26. Lavollay, M., Arthur, M., Fourgeaud, M., Dubost, L., Marie, A., Riegel, P., etal. (2009) The beta-lactam-sensitive D, D-carboxypeptidase activity of Pbp4 controls the L, D and D, D transpeptidation pathways in Corynebacterium jeikeium Mol Microbiol 74: 650-661.
27. Lavollay, M., Fourgeaud, M., Herrmann, J.L., Dubost, L., Marie, A., Gutmann, L., etal. (2011) The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L, D-transpeptidases. J Bacteriol 193: 778-782.
28. Leyh-Bouille, M., Bonaly, R., Ghuysen, J.M., Tinelli, R., and Tipper, D. (1970) LL-diaminopimelic acid containing peptidoglycans in walls of Streptomyces sp. and of Clostridium perfringens (type A). Biochemistry 9: 2944-2952.
29. Mahapatra, S., Scherman, H., Brennan, P.J., and Crick, D.C. (2005) N Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J Bacteriol 187: 2341-2347.
30. Mahapatra, S., Crick, D.C., McNeil, M.R., and Brennan, P.J. (2008) Unique structural features of the peptidoglycan of Mycobacterium leprae J Bacteriol 190: 655-661.
31. Mainardi, J.L., Legrand, R., Arthur, M., Schoot, B., van Heijenoort, J., and Gutmann, L. (2000) Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium J Biol Chem 275: 16490-16496.
32. Mainardi, J.L., Morel, V., Fourgeaud, M., Cremniter, J., Blanot, D., Legrand, R., etal. (2002) Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium J Biol Chem 277: 35801-35807.
33. Mainardi, J.L., Fourgeaud, M., Hugonnet, J.E., Dubost, L., Brouard, J., Ouazzani, J., etal. (2005) A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathway. J Biol Chem 280: 38146-38152.
34. Peltier, J., Courtin, P., Meouche, I.E., Lemee, L., Chapot-Chartier, M., and Pons, J.L. (2011) Clostridium difficile has an original peptidoglycan structure with a high level of N-acetylglucosamine deacetylation and mainly 3-3 cross-links. J Biol Chem 286: 29053-29062.
35. Ramakrishnan, L., Federspiel, N.A., and Falkow, S. (2000) Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288: 1436-1439.
36. Raymond, J.B., Mahapatra, S., Crick, D.C., and Pavelka, M.S. (2005) Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. J Biol Chem 280: 326-333.
37. Rezwan, M., Laneelle, M.A., Sander, P., and Daffe, M. (2007) Breaking down the wall: fractionation of mycobacteria. J Microbiol Methods 68: 32-39.
38. Sacco, E., Hugonnet, J.E., Josseaume, N., Cremniter, J., Dubost, L., Marie, A., etal. (2010) Activation of the L, D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D, D-carboxypeptidase in Enterococcus faecium Mol Microbiol 75: 874-885.
39. Sauvage, E., Kerff, F., Terrak, M., Ayala, J.A., and Charlier, P. (2008) The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 32: 234-258.
40. Takayama, K., Keith, A.D., and Snipes, W. (1975) Effect of isoniazid on the protoplasmic viscosity in Mycobacterium tuberculosis Antimicrob Agents Chemother 7: 22-24.
41. Tuomanen, E., and Cozens, R. (1987) Changes in peptidoglycan composition and penicillin-binding proteins in slowly growing Escherichia coli J Bacteriol 169: 5308-5310.
42. Van Heijenoort, J. (1994) Biosynthesis of bacterial peptidoglycan unit. In The Bacterial Cell Wall. Ghuysen, J.M., and Hakenbeck, R. (eds). Amsterdam, The Netherlands: Elsevier, pp. 39-54.
43. Wayne, L.G., and Hayes, L.G. (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64: 2062-2069.
44. Wayne, L.G., and Sohaskey, C.D. (2001) Nonreplicating persistence of Mycobacterium tuberculosis Annu Rev Microbiol 55: 139-163.
45. Wietzerbin, J., Das, B.C., Petit, J.F., Lederer, E., Leyh-Bouille, M., and Ghuysen, J.M. (1974) Occurrence of d-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry 13: 3471-3476.
46. Wright, A., Zignol, M., Van Deun, A., Falzon, D., Gerdes, S.R., Feldman, K., etal. (2009) Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373: 1861-1873.
47. Yagi, T., Mahapatra, S., Mikusova, K., Crick, D.C., and Brennan, P.J. (2003) Polymerization of mycobacterial arabinogalactan and ligation to peptidoglycan. J Biol Chem 278: 26497-26504.
48. Yew, W.W., and Leung, C.C. (2008) Management of multidrug-resistant tuberculosis: update 2007. Respirology 13: 21-46.
49. Yuan, Y., Zhu, Y., Crane, D.D., and Barry, C.E., 3rd (1998) The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis Mol Microbiol 29: 1449-1458.